Daniel Erdmann is currently the Director of Market Access at Pfizer, a position they have held since 2023. Previously, Daniel served in various roles related to AMNOG at GKV-Spitzenverband, including Acting Team Lead, Team Lead, and Advisor. They also worked as a Research Associate at Universität Mannheim and as a Lecturer at Hochschule Fresenius. Daniel earned a Ph.D. in Economics from Universität Mannheim and has additional experience as a visiting student at Queen's University.
This person is not in any teams
This person is not in any offices